http://www.aktiencheck.de aktiencheck.de aktiencheck.de Thu, 23 Apr 2026 00:14:26 +0200 2 http://www.aktiencheck.de/forum/Nash_Kanditat_Sagimet_Bio_jetzt_kaufen-A3CPAM-t584283 http://www.aktiencheck.de/forum/Nash_Kanditat_Sagimet_Bio_jetzt_kaufen-A3CPAM-t584283 Offenbar positive Ergebnisse, Bei x sind paar Posts die Aufschluss geben: - Big news for Sagimet Biosciences! Ascletis’ Denifanstat, licensed from Sagimet, crushed it in a Phase III trial for moderate to severe acne! Denifanstat (ASC40) showed statistically significant improvements, outperforming placebo in all endpoints. It was 98% more effective than sarecycline (18.6% vs 9.4%) and 178% more effective than doxycycline (18.6% vs 6.7%) in placebo-adjusted treatment success! Plus, it beat clascoterone cream by 60% (18.6% vs 11.6%). [<a href="http://www.aktiencheck.de/forum/Nash_Kanditat_Sagimet_Bio_jetzt_kaufen-A3CPAM-t584283">mehr</a>]